Business Context and Reporting Period
This Form 8-K is filed by International Surf Resorts, Inc. (not Cocrystal Pharma, Inc., as indicated in the metadata) for the reporting period ending February 22, 2011. The filing discloses a significant private placement financing transaction and a complete change in the company's executive leadership and board of directors.
Key Financial Metrics and Transaction Details
- Financing Proceeds: The Company entered into a Securities Purchase Agreement to raise $2,250,000 in aggregate gross proceeds.
- Instrument Structure: The capital was raised via 10% secured convertible promissory notes due August 24, 2011, and warrants to purchase securities.
- Debt Terms: Notes bear interest at 10% per annum. Principal and interest are due on the earlier of August 24, 2011, or the closing of a "Target Transaction" (acquisition of a business).
- Collateral: The notes are secured by a first priority security interest in all tangible and intangible assets of the Company. Additionally, a principal stockholder pledged 3,140,000 shares of Common Stock.
- Use of Proceeds: Proceeds are restricted to satisfying obligations under the agreement, making loans to specific entities, or other Buyer-approved purposes, with the intent to fund a Target Transaction within 120 days.
Material Changes and Leadership Transition
The filing reports a complete turnover of the Company's senior management and board:
- Resignations: Santana Martinez (Director) and Timothy Neely (Chief Operating Officer) resigned effective February 22, 2011. Eduardo Biancardi (Director, President, Treasurer, and Secretary) resigned effective February 24, 2011.
- Appointments: Roberto Prego Novo was appointed as Director, President, Principal Accounting Officer, and Secretary on February 24, 2011.
- Reasoning: The resignations were not due to any disagreement with the Company regarding operations, policies, or practices.
Outlook, Risks, and Contingencies
- Target Transaction Requirement: The Company intends to consummate an acquisition ("Target Transaction") within 120 days of the financing closing. Failure to close this transaction by the maturity date triggers severe penalties.
- Penalty Clauses: If the Target Transaction does not close by August 24, 2011, the Company must pay 150% of the outstanding principal plus accrued interest. If the note is not prepaid or converted by the maturity date, a $100,000 penalty fee applies.
- Warrant Terms: Warrants have a "full ratchet" anti-dilution adjustment for one year. The warrant coverage percentage increases (50% to 100%) if the Target Transaction is delayed beyond 120 or 150 days.
- Registration Rights: The Buyer has demand registration rights. If the Company fails to make a registration statement effective within specified deadlines, it must pay liquidated damages of 1% of the investment amount for each 30-day period of delinquency.
Investor Verification Checklist
- Verify the identity of the registrant; the filing is for International Surf Resorts, Inc., not Cocrystal Pharma, Inc.
- Confirm the status of the "Target Transaction" and whether the 120-day deadline for closing has been met or extended.
- Review the background and experience of the new President, Roberto Prego Novo, specifically regarding his transition from the pharmaceutical industry to this company.
- Assess the liquidity risk given the 150% repayment penalty if the acquisition does not close by August 24, 2011.
- Examine the pledged stock (3,140,000 shares) held by ISR Investments, LLC to understand the extent of insider collateralization.